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Signal transduction involving phosphatidylcholine hydrolysis has been investigated in human neutrophils (PMN) after 
in situ generation of PH]alkylacyl-sn-glycero-3-phosphocholine (PHlalkylacyl-GPC) by cell incubation with PH]alkylace- 
tyl-GPC. When PMN were stimulated with the chemotactic peptide N-formyl-Met-Leu-Phe (fMLP) or phorbol myristate 
acetate (PMA) in the presence of cytochalasin B, both I-0-alkyl-2-acyl-sn-glycero-3-phosphate (PA) and 1-0-alkyl-2- 
acyl-sn-glycerol (AAG) were generated. On addition of the agonists in the presence of ethanol, phosphatidylethanol (PE) 
was formed with a concomitant decrease in PA and AAG. These results indicate the presence of a phospholipase D (PLD) 
acting on phosphatidylcholine in human PMN. The kinetics of hydrolysis were quite different according to the stimulus. 
Whereas NLP induced a maximum rise in PA and AAG at 3&45 s, these products began to appear only after 1 min 
upon cell incubation with PMA. Similar amounts of products were formed at 1 mm with !MLP and only at 5 min with 
PMA. Although similar time courses of PA generation were obtained in the absence of cytochalasin B, AAG were no 
longer involved and therefore cannot account for intracellular second messenger under physiological conditions. Subcel- 
lular distribution studies demonstrated the exclusive location of PA and PE in the plasma membrane. The possible in- 
volvement of PA in respiratory burst activation is discussed. 
Polymorphonuclear leukocyte; Phospholipase D; Alkylacylglycerophosphocholine; Formylmethionylleucylphenylalanine, N-; Phorbol 
myristate acetate 
1. INTRODUCTION 
Phosphoinositide hydrolysis by phospholipase C 
is a general process involved in signal transduction 
[I], leading to the generation of diacylglycerol and 
the subsequent activation of protein kinase C [2]. 
More recently, another source of diglycerides has 
emerged through the hydrolysis of alkylacyl-GPC 
by a specific phospholipase C [3,4]. Interestingly, 
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AAG inhibits protein kinase C activation [5] and 
therefore could contribute to turning off protein 
kinase C-related transduction processes. PMN ex- 
hibit high levels of alkylacyl-GPC [6] and are ac- 
tivated by a large variety of stimuli during 
inflammation. In addition, a source of diglycerides 
different from phosphatidylinositol has been 
pointed out in human PMN [7,8]. Therefore, we 
focused our attention on the characterization of 
alkylacyl-GPC hydrolysis in human PMN upon 
stimulation by two different types of stimuli: 
fMLP and phorbol esters. The most recent 
developments in studies of phosphatidylcholine 
hydrolysis have emphasized the role of a PLD in 
several cell models [g-12]. In this respect, a recent 
work in human neutrophil suggests the activation 
of a PLD by various agonists [ 131. In order to 
discriminate definitively between the two possible 
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routes for alkylacyl-GPC hydrolysis, i.e. through 
phospholipase C or phospholipase D activity, we 
have based the present work on the exclusive pro- 
perty of phospholipase D of transphosphatidyla- 
tion [ 141. We demonstrate here the differential 
activation of a PLD upon cell challenge with 
fMLP and PMA. Cytochalasin B appeared to 
enhance the activity of a phosphatidate 
phosphatase [15] since, in its absence, only PA 
were formed. 
2. MATERIALS AND METHODS 
[3H]Concanavalin A (60 Ci/mmol), I-0-[‘Hloctadecyl-2- 
acetyl-sn-glycero-3-phosphocholine (132-179 Ci/mmol, [3H]- 
PAF) were purchased from Amersham (England); Plasmagel 
from Laboratoires Roger Bellon (France); Percoll from Phar- 
macia (France); and fMLP, cytochalasin B, PMA, pnitro- 
phenyl phosphate, fatty-acid-free bovine serum albumin and 
PA from Sigma (France). 
2.1. Cell incubation 
Cells (lO’/ml in 137 mM NaCl, 2.7 mM KCl, 5.5 mM 
glucose, 20 mM Hepes, pH 7.4) were isolated on Percoll 
[16,17]. Cells were then incubated for 15 min at 37°C with 
[‘H]PAF (7-14 nM, 1 ,&i/10’ cells) and washed twice with 
Hepes buffer containing 2.5% (w/v) bovine serum albumin. 
After incubation, 53 f 3.7% of the initial [‘H]PAF was incor- 
porated into cells, with 80% of the total cell radioactivity in 
alkylacyl-GPC, 17% in unmetabolised PAF, and 3% in minor 
compounds. 
Stimulation was performed at 37°C in 137 mM NaCI, 
2.7 mM KCl, 5.5 mM glucose, 1.3 mM CaClz, 1 .O mM MgCls, 
buffered with 20 mM Hepes. Cells were first incubated for 
10 min with 5 PM cytochalasin B. Thereafter, either fMLP 
(1 pM, unless otherwise stated) or PMA (100 nM) was added 
and incubation allowed to proceed up to 5 min. Parallel ex- 
periments were performed in the presence of ethanol (0.5070, 
v/v) which was added together with agonist. 
2.2. Phospholipid analysis 
Lipids were extracted according to the acidic procedure of 
Bligh and Dyer [18]. EDTA (2.6 mM final) and cold PA 
(lO,cg/sample) were also added. Products of [3H]alkylacyl- 
GPC hydrolysis were separated by TLC as described by Cohen 
et al. [19]. Plates were scanned for radioactivity using an 
automatic TLC linear analyzer (Berthold LB 2848). Radioactive 
spots were scraped off and counted for radioactivity using 
Picofluor as scintillation fluid. 
2.3. Intracellular localization of products from phospholipase 
D activity 
Stimulation was stopped by adding a large volume of cold 
Hepes buffer. Cells were pelleted and suspended in the lysis buf- 
fer, disrupted by cavitation and fractionated on a Percoll gra- 
dient as in [15,16]. Lipids were then directly extracted from 
gradient fractions: 7 ml isopropanol containing 2% acetic acid 
and cooled to - 20°C were mixed with the 2 ml gradient frac- 
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tion and centrifuged at 3000 x g for 15 min at 4°C. Lipids were 
extracted from the supernatant by addition of 8 ml methanol 
(with 2% acetic acid), 16 ml chloroform and 14 ml water. The 
organic phase was concentrated and the lipids separated as 
given above. 
2.4. Lipid standards 
[‘H]Alkylacyl-GPC was obtained by incubation of [3H]PAF 
with cultures of HL-60 cells. The labeled phospholipid was sub- 
mitted to the action of phospholipase C, yielding [3H]AAG, or 
to PLD, forming [3H]PA and [3H]PE. 
2.5. Data presentation 
Results are expressed as means f SE from 3 separate ex- 
periments. Curves were drawn using Sigmaplot software (from 
Sigma). 
3. RESULTS 
3.1. I3H/Alkyiacyl-GPC hydrolysis upon cell 
stimulation with fMLP 
In resting labeled PMN, only trace amounts of 
[3H]PA and [3H]AAG were detected, as shown in 
fig.lA. Upon cell stimulation by fMLP, however, 
a net increase in both products was monitored 
(fig.lB). When ethanol was added together with 
fMLP, formation of PE was demonstrated as 
depicted in fig.lC. In all cases, triglycerides re- 
mained constant. 
Time course experiments performed in the 
absence of ethanol demonstrated a very rapid rise 
in [3H]PA at 30 s with concomitant generation of 
AAG upon cell challenge with fMLP (fig.2A,C). 
In the presence of ethanol, both products were 
similarly decreased, whereas PE was synthesized 
(fig.2B). Since AAG was affected to the same ex- 
tent as [3H]PA by the presence of ethanol, we 
assumed that AAG was formed via hydrolysis of 
the initial PA. Both PA and AAG remained almost 
constant after 60 s, indicating that enzyme activa- 
tion was over at that time. Enzyme activity was 
noticeable at 10 nM fMLP, increasing continuous- 
ly at least up to 10pM effector (fig.3). When PE 
was formed (fig.3B), the amounts of both PA and 
DG were similarly diminished (fig.3A,C) as had 
also been observed in the time course studies 
(fig.2). 
3.2. fH]Alkyiacyl-GPC hydrolysis upon Ph4N 
stimulation with phorbol ester 
At variance with fMLP, PA generation induced 
by PMA began only after 1 min (fig.4A), the rate 
increasing thereafter at least up to 5 min. Forma- 
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Fig. 1. Representative TLC scans of radioactive products. PMN 
labeled with [‘H]PAF were incubated at 37°C for 1 min and 
processed for lipid analysis as described in section 2. (A) 
Resting neutrophils; (B) stimulation by WLP; (C) as in (B), 
fMLP in the presence of ethanol (O.Wo, v/v final). PL, major 
phospholipids; PA, alkylacylglycerophosphate; PEt, phospha- 
tidylethanol; DC, alkylacylglycerol; TG, triglyceride. 
tion of 13H]AAG (fig4C) was delayed as com- 
pared with PA (fig.4A). In addition, no effect of 
ethanol on AAG radioactivity was observed prior 
to 2 min, indicating that formation of AAG above 
the basal level did not take place during that 
period. Ethanol induced the formation of PE 
(fig.4B) with kinetics that parelleled quite well 
those of PA (fig.rlA). Because of the metabolic 
deviation to PE, PA underwent a decrease (fig.4A) 
and, to a less extent, AAG. Thus, as compared to 
fMLP, PMA-induced alkylacyl-GPC hydrolysis 
was a slow process, since the same amounts of pro- 
ducts (in the presence or absence of ethanol) were 
obtained at 45 s with fMLP and 5 min with PMA 
(cf. figs 2 and 4). 
3.3. Hydrolysis of fH]alkylacyCGPC in the 
absence of cytochalasin B 
In the absence of cytochalasin B, a rise in PA 
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Fig.2. Time course of [3H]PA and [‘H]AAG generation upon 
PMN stimulation with WLP. Products derived from 
[3H]alkylacyl-GPC hydrolysis with 1 ,uM fMLP were checked in 
the absence (- , open symbols) or presence (+ , full symbols) of 
ethanol in the incubation medium: (A) [“HIPA, (B) [“HJPE, (C) 
[3H]AAG. Results are expressed as percentages of total 
radioactivity per sample (6 x 10’ dpm/lO’ cells). 
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Fig.3. Concentration dependence of fMLP-induced [“Hlalkyl- 
acyl-GPC hydrolysis in human PMN. Stimulation was 
performed for 1 min at 37°C. Data shown as in fig.2. 
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Fig.4. Time course of [3H]PA and [‘H]AAG formation upon 
PMN stimulation with PMA. For details and data expression, 
see fig.2. (A) [3H]PA, (B) [3H]PE, (C) [3H]AAG. [PMA]: 
100 nM. 
content was also detected within 1 min in the 
presence of fMLP (fig.SA). Instead AAG ap- 
peared constant as a function of incubation time. 
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Fig.5. [3H]Alkylacyl-GPC hydrolysis induced by fMLP and 
PMA in the absence of cytochalasin B. (A) Cells were labeled 
with [‘Hlalkyl-lyso-GPC (80-120 Ci/mmol) and stimulated 
with 100 nM fMLP, in the absence of ethanol [PA (v), AAG 
(o)]. (B) Effect of PMA in cells labeled from [‘Hlalkylacetyl- 
GPC in the absence (- , open symbol) or presence of ethanol 
(+ , full symbol). Only PA (A , A) and AAG (inset: (0,o) have 
been plotted. 
With PMA as an agonist (fig.SB), PA appeared at 
a rate similar to that observed in the presence of 
cytochalasin B (fig.4A). At variance with the 
results in fig.4C, AAG remained at basal level up 
to 5 min (fig.SB, inset) and consequently ethanol 
decreased only the amount of PA (fig.SB). 
l’herefore, in the absence of cytochalasin B, PA 
was the only product formed from alkylacyl-GPC 
with both agonists. 
3.4. Intracellular localization of PLD products 
As shown in fig.6A, the distributions of pro- 
ducts found in the plasma membrane and granules 
displayed opposite profiles across the gradient as 
reported earlier [ 161. Whereas [3H]alkylacyl-GPC 
labeling exhibited a bimodal distribution (fig.6B), 
Fractions 
Fig.6. Subcellular distribution of phospholipase D activity. 
After stimulation (1 min for WLP; 5 min for PMA), cells were 
fractionated as in [16] and phospholipids directly extracted 
from gradient fractions (see text). (A) Profiles of the various 
markers, i.e. [‘Hlconcanavalin A [plasma membrane (v)] and 
N-acetyl j3-D-glucosaminidase [granules (+)I. (B) Total 
radioactivity of each gradient fraction. On stimulation of cells 
with either fMLP (C)or PMA (D) both [‘HIPA (A) and [3H]PE 
(m) were found in the plasma membrane. 
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the hydrolysis products t3H]PA and [3H]PE were 
found exclusively in the plasma membrane upon 
cell stimulation by fMLP (fig.6C) or PMA 
(fig.6D). 
4. DISCUSSION 
The present results provide evidence in support 
of alkyl-PA as being the first product formed from 
[3H]alkylacyl-GPC hydrolysis, when human PMN 
are challenged with either fMLP or PMA. Based 
on data obtained on transphosphatidylation, it is 
concluded that PA formation occurs via a PLD 
acting on alkylacyl-GPC, AAG appearing as a 
secondary product formed through PA hydrolysis 
by phosphatidate phosphohydrolase. The PLD ac- 
tivity was monitored on a total cell basis, with the 
substrate being generated in situ by incorporation 
of [3H]PAF. This procedure was chosen because it 
allows specific labeling of choline glycerophospho- 
lipid. However, we cannot exclude diacyl-GPC as 
being the probable substrate of the PLD described 
here [13]. Cytochalasin B has been revealed to be 
a useful tool to amplify PMN stimulation [20]. 
Indeed, the amounts of PA formed in fMLP- 
stimulated PMN increased from 1.8 to 2.6% upon 
cytochalasin B addition. However, the main effect 
of cytochalasin B was to promote the appearance 
of AAG, which was no longer concerned in the 
process of [3H]alkylacyl-GPC hydrolysis induced 
by fMLP or PMA (figSA), at variance with a re- 
cent report [13]. 
The question then arises of the physiological 
significance of this new PLD activity, and whether 
PA can act as an intracellular second messenger. 
One of the PMN responses upon stimulation is the 
activation of the membrane-bound NADPH ox- 
idase responsible for the ‘respiratory burst’. There 
is a body of evidence indicating that diacylglycerol 
originating from either phosphatidylinositol or 
phosphatidylcholine cannot account for the entire 
activation process of the NADPH oxidase 
[8,21-241. For instance, the kinetics of formation 
of total diglyceride are not correlated with the 
respiratory burst induced by PAF, opsonized par- 
ticles, or fMLP (without cytochalasin B) [25]. In- 
stead, a correlation between 02 generation and PA 
has been pointed out [26] and a phosphatidyl- 
inositol-related PLD has been recently reported 
[27]. The kinetics of PA generation originating 
from alkylacyl-GPC reported in the present paper 
exhibit a striking similarity with the time course of 
the respiratory burst induced (without cytochalasin 
B) by fMLP and PMA [27]. Whereas the maxi- 
mum rise in the case of fMLP is at 30-45 s, the 
PMA-induced burst commences increasing only 
after 1 min [28]. In addition, the localization of 
PLD activity in the plasma membrane (fig.6) pro- 
vides further support for the direct activation by 
PA of NADPH oxidase in isolated plasma mem- 
branes of pig neutrophils [29]. Taken together, all 
of our data describe the stimulation of a phos- 
phatidylcholine-related PLD in human PMN, 
which could be involved in a second type of 
transduction sequence for NADPH oxidase ac- 
tivation. 
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